FDA questions skin reactions with AstraZeneca drug - BusinessWeek

[INCIID News Feed]

<img alt="" height="1" width="1" />
FDA questions skin reactions with AstraZeneca drug
BusinessWeek
Federal health regulators are questioning the safety of AstraZeneca&#39;s experimental lung drug for infants, saying it caused more skin reactions than a drug already on the market. The FDA posted its review of the drug online Friday morning. ...
Ex-MedImmune exec sues company, questions testingWashington Business Journal
AstraZeneca safety issues citedInvestor's Business Daily
FDA Staff Sees Allergic-Reaction Risk With MotavizumabNASDAQ
FierceBiotech
all 17 news articles &raquo;


More...